학술논문
Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”
Document Type
Letter
Author
Mallet, V.; Mandengue, P.D.; Vallet-Pichard, A.; Hollande, C.; Fontaine, H.; Pol, S.; Bock, K.; Voigtländer, T.; Wedemeyer, H.; Dellagi, M.; Beeker, N.; Tano, M.; Siorat, V.; Paubel, P.; Dufour, N.; Ricard, J.-D.; Gernez, C.; Isnard, P.; Duong Van Huyen, J.-P.; Frochot, V.; Letavernier, E.; Moga, L.; Landrieux, A.; Rautou, P.-E.; Pons-Kerjean, N.; Chouchana, L.; Burger, C.; Scemla, A.; de Tymowski, C.; Depret, F.; Dudoignon, E.; Lamhaut, L.; Flicoteau, R.; Rousseau, G.; Correas, J.-M.
Source
In: Journal of Hepatology . (Journal of Hepatology, October 2021, 75(4):990-992)
Subject
Language
English
ISSN
16000641
01688278
01688278